<DOC>
	<DOCNO>NCT00292526</DOCNO>
	<brief_summary>In cancer patient , increase troponin I soon chemotherapy strong predictor leave ventricular dysfunction poor cardiologic outcome . This information provide rationale development prophylactic strategy direct chemotherapy-induced cardiotoxicity ( CTIC ) . Activation renin-angiotensin system prove involved development progression cardiac dysfunction several clinical setting , suggest role occurrence CTIC . We investigate role treatment ACE-inhibitors prevention CTIC high-risk cancer patient .</brief_summary>
	<brief_title>Prevention Chemotherapy-induced Cardiotoxicity High-risk Patients</brief_title>
	<detailed_description />
	<mesh_term>Cardiotoxicity</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<criteria>Consecutive patient undergo highdose chemotherapy show early release Troponin I Contraindication ACEinhibitors Ongoing therapy betablockers , ACEinhibitors , angiotensinreceptors blocker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Chemotherapy induce cardiotoxicity</keyword>
	<keyword>Troponin</keyword>
	<keyword>Heart failure</keyword>
</DOC>